MicroRNA let-7 downregulates STAT3 phosphorylation in pancreatic cancer cells by increasing SOCS3 expression

Kripa Patel1, Anita Kollory1, Asami Takashima1

  • 1Cancer Center, Boston University School of Medicine, Boston, MA, United States.

Cancer Letters
|February 5, 2014
PubMed

Insights

Re-expressing microRNA let-7 in pancreatic cancer cells inhibits STAT3 signaling by increasing SOCS3. This reduces pancreatic ductal adenocarcinoma cell growth and migration, offering a potential therapeutic strategy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Regulation

Background:

  • Signal transducer and activator of transcription 3 (STAT3) signaling is often hyperactivated in pancreatic cancers.
  • Downregulation of microRNA let-7 expression is a hallmark of pancreatic ductal adenocarcinoma (PDAC).

Purpose of the Study:

  • To investigate the functional role of let-7 in regulating STAT3 signaling and PDAC progression.
  • To elucidate the molecular mechanism by which let-7 influences STAT3 activation in pancreatic cancer cells.

Main Methods:

  • Restoration of let-7 expression in poorly-differentiated PDAC cell lines.
  • Analysis of STAT3 phosphorylation and downstream signaling.
  • Assessment of PDAC cell growth and migration.
  • Evaluation of STAT3 protein, IL-6, and SOCS3 expression levels.

Main Results:

  • Re-expression of let-7 significantly reduced STAT3 phosphorylation and downstream signaling in PDAC cells.
  • let-7 restoration decreased PDAC cell growth and migration.
  • let-7 did not affect STAT3 or IL-6 expression but enhanced cytoplasmic SOCS3 expression.
  • Increased SOCS3 expression by let-7 inhibited JAK2-mediated STAT3 activation.

Conclusions:

  • let-7 acts as a tumor suppressor in PDAC by inhibiting STAT3 signaling through SOCS3.
  • Modulating let-7 expression represents a potential therapeutic avenue for pancreatic cancer.
  • The let-7/SOCS3/STAT3 axis offers a novel target for pancreatic cancer treatment.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.1K
MicroRNAs01:22

MicroRNAs

9.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.5K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
10.2K